Geritrex Holdings, Inc., a leading manufacturer and distributor of niche dosage form OTC products and pharmaceuticals and a portfolio company of BelHealth Investment Partners, LLC, a New York-based healthcare private equity firm, announced today that is has completed the acquisition of Unipack Inc.

Unipack is a leading private label manufacturer and distributor of OTC pharmaceuticals to some of the country’s largest retail chains. Unipack’s primary products include suppositories as well as topical ointments and creams.

Unipack was founded in 1981 by brothers Harilal and Dinesh Patel and its corporate headquarters is in Pittsburgh, PA.

Tim Sawyer, CEO and Executive Chairman of Geritrex, said, “In Unipack, the Patel family has built a strong business with a solid reputation for quality and customer service. Unipack complements Geritrex’s existing business and we are excited to expand both our product offering and customer base with a significant share in the private label retail market across a number of products. Furthermore, Unipack adds a number of new product lines to our portfolio, including an attractive portfolio of suppository products. We are excited about the cross selling opportunities and the overall growth potential of the combined business.”

Nathan Kronforst, Managing Director of BelHealth and Geritrex Board Member, added, “We have been focused on both organic and acquisitive strategies to expand Geritrex’s product capabilities and categories and are pleased to be expanding into the suppository market through the acquisition of Unipack. Following this acquisition, Geritrex has a diversified mix of products across multiple niche dosage forms including topicals, liquids, powders and suppositories. This set of manufacturing capabilities positions Geritrex as a versatile supplier and partner to customers across both the retail and institutional channels.”

About Geritrex

Founded in 1978 and headquartered in Middletown, New York, Geritrex is a manufacturer and distributor of niche dosage form OTC products and pharmaceuticals to customers across a number of institutional channels as well as consumers through traditional retail channels. The Company’s core product categories include dermatological, analgesic, digestive and cough/cold products across various dosage forms including creams and ointments, liquids, powders and suppositories.

About BelHealth Investment Partners

BelHealth Investment Partners, based in New York, is a healthcare private equity firm focused on lower middle market companies. BelHealth has a unique combination of investing, executive management and entrepreneurial experience. BelHealth acquires majority positions in entrepreneur-owned companies that it believes would benefit from its extensive operating and private equity investment expertise. The firm invests across three core healthcare segments: Services, Products and Distribution. BelHealth is investing from its current $350 million fund.